Association of stem cell marker CD133 expression with dissemination of glioblastomas
Takamasa Kayama(Yamagata University), Kaori Sakurada(Miyoshi Kasei (Japan)), Chifumi Kitanaka(Yamagata University), Kenichiro Asano(Hirosaki University), Kazuo Mizoi(Tohoku University), Toshihiro Kumabe(Kitasato University), Hiroki Ohkuma(Hirosaki National Hospital), Atsushi Satō(National Cancer Center Hospital East), Toshio Sasajima(Iwate Medical University), Takaaki Beppu(Iwate Medical University), Akira Ogawa(Japan Aerospace Exploration Agency), Teiji Tominaga(Tohoku University)
Cited by 33
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
The Tohoku Medical Megabank Project: Design and Mission
|Journal of Epidemiology|2016|386